drugset / Trial / NCT01210066

Pain, Opioids and Pro-Inflammatory Immune Responses

NCT01210066

Phase 1 Terminated 21 enrolled University of California, Los Angeles
RandomizedFactorialOpen-labelBasic science

Summary

Providing pain management to the patient who abuses prescription opioids presents a clinical challenge, not only due to concerns about "drug-seeking", but because they have increased sensitivity to pain, a phenomenon identified as opioid-induced hyperalgesia (OIH). In an effort to improve pain treatment, the aims of the proposed work are to evaluate the analgesic and hyperalgesic effects of opioids to acute pain in this vulnerable population, and to examine the role of opioid-induced proinflammatory changes in these responses.

Timeline

Start
2010-07
Primary completion
2012-05
Completion
2012-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fentanyl Other / unclassified 1 ug/kg Intravenous

Indications

No indication recorded.